Immudicon
Immudicon was founded in 2011, is headquartered in United States, and lists 1–10 employees.
- Employees
- 1–10
- Founded
- 2011
- Business Model
- B2B
- Website
- immudicon.com
About
Immudicon develops MacroVax, an intracellular vaccine delivery technology that activates the immune system against cancer.
Summary
Immudicon is a Biotech company based in United States, founded in 2011. It lists 1–10 employees.
Similar Companies
Tiantan Biological / China Biologic (泰邦生物集团)
China's leading blood products manufacturer
Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired
Specialty pharmaceutical company
Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs
Altos Labs combines academic science and industry development to create medicines that restore ce...
San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immudicon"><img src="https://indexed.vc/api/badge/company/immudicon" alt="Immudicon on Indexed.vc" width="260" height="76" /></a>